You are here

IPOs

Alto Neuroscience preps IPO to push precision psychiatry therapies through the clinic

Fierce Biotech

Tue, 01/16/24 - 09:54 am

Alto Neuroscience

machine learning

artificial intelligence

Cancer biotech ArriVent Biopharma files for a $100 million IPO

Renaissance Capital

Mon, 01/8/24 - 11:38 am

ArriVent Biopharma

Gene editing startup Metagenomi files for an IPO

BioPharma Dive

Sun, 01/7/24 - 04:16 pm

CG Oncology plans IPO plunge ahead of phase 3 bladder cancer drug readout

Fierce Biotech

Wed, 01/3/24 - 09:35 am

After a record run, fewer biotechs are going public. Here’s how they’re performing.

BioPharma Dive

Tue, 12/19/23 - 11:42 am

Cargo Therapeutics

Lexeo Therapeutics

Neumora Therapeutics

Fractyl, hoping its GLP-1 gene therapy can take on Wegovy, plans IPO

Fierce Biotech

Fri, 12/15/23 - 09:41 am

Chinese biotech firm HighTide Therapeutics slashes Hong Kong IPO size by 80% to US$35.6 million

Yahoo/South China Morning Post

Thu, 12/14/23 - 09:44 am

HighTide Therapeutics

Biopharma’s top 5 IPOs of 2023 (so far)

Pharma Voice

Thu, 11/30/23 - 10:01 am

Apogee Therapeutics

Neumora Therapeutics

Mineralys Therapeutics

Playing in the Hot Obesity Market, Carmot Braves Chilly IPO Waters

BioSpace

Mon, 11/20/23 - 10:07 am

Carmot Therapeutics

WuXi Biologics bioconjugates spinout plans $470 million IPO

Biopharma Reporter

Thu, 11/9/23 - 11:30 pm

IPO Update: Cargo Therapeutics Readies Plans For $300 Million IPO

Seeking Alpha

Mon, 11/6/23 - 07:21 pm

Cargo Therapeutics

large B cell lymphoma

WuXi Biologics' medical research unit eyes up to $471 million in Hong Kong IPO

Reuters

Mon, 11/6/23 - 07:15 pm

Lexeo drops share price at last minute in attempt to raise $100M IPO

Fierce Biotech

Fri, 11/3/23 - 11:53 am

Lexeo Therapeutics

Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024

BioPharma Dive

Fri, 10/27/23 - 11:39 am

5 financial challenges facing the medtech sector

Medtech Dive

Tue, 10/10/23 - 11:50 pm

How biotech IPOs performed in the third quarter

BioPharma Dive

Tue, 10/3/23 - 10:28 am

Neumora Therapeutics

Mira Pharmaceuticals

Turnstone Biologics

Apogee Therapeutics

Sagimet Biosciences

60 Degrees Pharma

Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought

BioSpace

Mon, 10/2/23 - 10:40 am

Lexeo Therapeutics

genetic medicine

Adlai Nortye IPO gives old Novartis cancer drug new life

BioPharma Dive

Fri, 09/29/23 - 10:22 am

head and neck cancer

Neumora Therapeutics stock surges as Amgen confirmed as major shareholder

Proactive Investors

Thu, 09/28/23 - 10:42 am

Emcure Pharma plans to launch $400-500 million IPO in 2024

Mint

Tue, 09/26/23 - 10:21 am

Emcure Pharmaceuticals

Pages